Pulmonary TB

1
Pulmonary TB
TUBERCULOSIS
2
BY

• PROF.
• AZZA EL- MEDANY
• Department of Pharmacology

3
OBJECTIVES

• At the end of lecture , the students should
• Discuss the etiology of tuberculosis
• Discuss the common route for transmission of the
  disease
• Discusses the out line for treatment of
  tuberculosis
• Discuss the drugs used in the first second line
  

4
OBJECTIVES ( continue)

• Regarding
• The mechanism of action
• Adverse effects
• Drug interactions
• Contraindication
• Discuss tuberculosis pregnancy
• Discuss tuberculosis breast feeding

5
Etiology

• Mycobacterium tuberculosis, an acid fast bacillus
  with three types known to infect man causing
  pulmonary TB
• The human type, commonest
• The bovine type
• The african type

6

• Robert Koch was the first
• to see Mycobacterium tuberculosis with his
  staining technique in 1882.

7
Disease information
  

• Each year, 1 of the global population is
  infected.

8
(No Transcript)
9
(No Transcript)
10
(No Transcript)
11
Tuberculosis

• Common sites of infections
• Apical areas of lung
• Renal parenchyma
• Growing ends of bones
• Where oxygen tension is high

12
Treatment Of Tuberculosis

• Preventing drug resistance is the most important
  reason to use drug combination.
• Periods of treatment ( minimum 6 months)
• Drugs are divided into two groups
• First line 2. Second line

13
Antimycobacterial drugs

• First line
• Isoniazid (INH)
• Rifampin
• Ethambutol
• Streptomycin
• Pyrazinamide

14
Never use a single drug therapy

• Isoniazid rifampin combination administered for
  9 months will cure 95-98 of cases .
• Addition of pyrazinamide for this combination for
  the first 2 months allows total duration to be
  reduced to 6 months.

15
Isoniazid ( INH)

• Bactericidal
• Is effective against intracellular
  extracellular bacilli

16
Mechanism Of Action

• Inhibits the synthesis of mycolic acid
• ( inhibits bacterial cell wall )

17
Clinical uses

• Treatment of TB
• .
• Treatment of Latent tuberculosis in patients with
  positive tuberculin skin test
• Prophylaxis against active TB in individuals
  who are in great risk .

18
Adverse effects

• Peripheral neuritis
• (pin needles sensation in the feet )
• Optic neuritis atrophy.
• Pyridoxine should be given with INH

19
Drug Interactions of INH

• Enzyme inhibitor of hepatic microsomal enzymes

20
Rifampin

• Bactericidal
• Inhibits RNA synthesis

21
Site of Action

• Intracellular bacilli
• Extracellular bacilli

22
Clinical uses

• Treatment of TB
• Prophylaxis of active TB.

23
Adverse effects

• Harmless red-orange discoloration of body
  secretions ( saliva, sweat ..).
• Hepatitis

24
Drug Interactions

• Enzyme inducer of hepatic microsomal enzymes

25
Ethambutol

• Bacteriostatic
• Inhibits mycobacterial arabinosyl transferase (
  alters the cell barrier )

26
Site Of Action

• Intracellular Extracellular bacilli

27
Clinical uses

• Treatment of tuberculosis in combination with
  other drugs.

28
Adverse effects

• Impaired visual acuity
• Loss of discrimination of red-green color
• Contraindicated in children under 5 years.

29
Pyrazinamide

• Bactericidal
• Mechanism of action is unknown .

30
Site Of Action

• Active against Intracellular Bacilli

31
Clinical uses

• In multidrug resistance cases.
• Important in short course (6 months) regimen.
• Prophylaxis of TB .

32
Adverse effects

• Hepatotoxicity
• Hyperuricemia ( gouty arthritis )

33
Streptomycin

• Bactericidal
• Inhibits protein synthesis
• Active on extracellular bacilli

34
Clinical uses

• Severe , life-threating form of T.B. as
  meningitis, disseminated disease.

35
Adverse Effects

• Ototoxicity
• Nephrotoxicity
• Neuromuscular block

36
Indication of 2nd line treatment

• Resistance to the drugs of 1st line.
• Failure of clinical response
• Contraindication for first line drugs.
• Atypical tuberculosis

37
Ethionamide

• Inhibits the synthesis of mycolic acid

38
Clinical uses

• Treatment of TB

39
Adverse Effects

• Severe gastric irritation
• Neurological side effect

40
Fluoroquinolones (Ciprofloxacin )

• Effective against multidrug- resistant
  tuberculosis.

41
Rifabutin

• Inhibits RNA synthesis

42
Aminosalicylic Acid (PAS).

• Bacteriostatic
• Inhibits Folic acid synthesis.

43
Clinical uses

• Treatment of different forms of TB.

44
Adverse effects

• GIT upset
• Crystalluria

45
TB Pregnancy

• Untreated TB represents a great risk to the
  pregnant woman her fetus than the treatment
  itself.
• First line drugs are given for 9 months in normal
  doses
• Streptomycin is the last alternative in treatment

46
TB Breast Feeding

• It is not a contraindication to receive drugs ,
  but caution is recommended

47
(No Transcript)
48
(No Transcript)